[Clinical characteristics of RUNX1-mutated acute myeloid leukemia patients].

PubMed 2026 Open access

Read full text
Authors: Y X Dong, W J Dai, W Q Zhang, B B Xie, Q Zhang, Y X Dong, Haibo Qin, Zhimin Zhai, Q S Tao, L L Tao
DOI: 10.3760/cma.j.cn121090-20250427-00202
Cited by: 0

Abstract

>0.05). Patients with concurrent RUNX1 and DNMT3A or ASXL1 mutations portend a poorer prognosis, and the cooccurrence of FLT3-ITD mutation further leads to inferior therapeutic outcomes.

Fields of Study & Subjects

Acute Myeloid Leukemia Research Retinoids in leukemia and cellular processes Chromatin Remodeling and Cancer

Publication details

Journal / source
PubMed
Volume
47
Issue
1
Pages
69–73
Publication date
14 January 2026
Language
ZH